The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects

Clinical trial NCT03462173 · COMPLETED

Trial details

NCT number: NCT03462173
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Hepatitis c

Start date: 2014-12-03
Primary completion: 2015-01-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.